PAR paradigm biopharmaceuticals limited..

Back to the Future, page-8

  1. 10,383 Posts.
    lightbulb Created with Sketch. 1414
    Most won't be aware of this, however, the ATO issued issued tax ruling TR 2008/1, which specifically outlaws arrangements where “...in substance there is no significant change in the taxpayer’s economic exposure to, or interest in, the asset, or where that exposure or interest may be reinstated by the taxpayer”. In other words, the ATO prevents investors from selling a stock in one financial year to take advantage of a capital loss event, only to buy that stock again in the new financial year. This is known as a “wash sale” and the ATO will disallow the loss if the sole intention of the sale was to minimise tax.

    So those selling PAR (or other holdings) into FY end need to be very cautious as they may end up losing on two counts if they're entertaining re-entry. To comply with tax law as an investor (as opposed to classifying yourself as a trader) and receive the CGT discount you are effectively required to make a conviction call with a long-dated horizon.

    https://www.ato.gov.au/law/view/pdf/pbr/tr2008-001.pdf

    p.s. And thanks to those in advance for making one aspect of the market predictable.




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
44.5¢
Change
0.015(3.49%)
Mkt cap ! $176.8M
Open High Low Value Volume
45.0¢ 45.0¢ 43.0¢ $364.9K 828.8K

Buyers (Bids)

No. Vol. Price($)
2 55155 43.5¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 24999 2
View Market Depth
Last trade - 16.10pm 08/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.